These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy. Holcomb B; Yip-Schneider M; Schmidt CM Pancreas; 2008 Apr; 36(3):225-35. PubMed ID: 18362834 [TBL] [Abstract][Full Text] [Related]
8. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Allen CT; Ricker JL; Chen Z; Van Waes C Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170 [TBL] [Abstract][Full Text] [Related]
9. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression. Shishodia S; Aggarwal BB Oncogene; 2006 Mar; 25(10):1463-73. PubMed ID: 16331273 [TBL] [Abstract][Full Text] [Related]
10. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252 [TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-kappaB: a friend or a foe in cancer? Shishodia S; Aggarwal BB Biochem Pharmacol; 2004 Sep; 68(6):1071-80. PubMed ID: 15313403 [TBL] [Abstract][Full Text] [Related]
12. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Bassères DS; Baldwin AS Oncogene; 2006 Oct; 25(51):6817-30. PubMed ID: 17072330 [TBL] [Abstract][Full Text] [Related]
13. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224 [TBL] [Abstract][Full Text] [Related]
14. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells. Braeuer SJ; Büneker C; Mohr A; Zwacka RM Mol Cancer Res; 2006 Oct; 4(10):715-28. PubMed ID: 17050666 [TBL] [Abstract][Full Text] [Related]
15. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Tse AK; Wan CK; Shen XL; Yang M; Fong WF Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613 [TBL] [Abstract][Full Text] [Related]
16. Host nuclear factor-kappaB activation potentiates lung cancer metastasis. Stathopoulos GT; Sherrill TP; Han W; Sadikot RT; Yull FE; Blackwell TS; Fingleton B Mol Cancer Res; 2008 Mar; 6(3):364-71. PubMed ID: 18337446 [TBL] [Abstract][Full Text] [Related]
17. Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy. Sourbier C; Danilin S; Lindner V; Steger J; Rothhut S; Meyer N; Jacqmin D; Helwig JJ; Lang H; Massfelder T Cancer Res; 2007 Dec; 67(24):11668-76. PubMed ID: 18089796 [TBL] [Abstract][Full Text] [Related]
18. Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells. Yemelyanov A; Gasparian A; Lindholm P; Dang L; Pierce JW; Kisseljov F; Karseladze A; Budunova I Oncogene; 2006 Jan; 25(3):387-98. PubMed ID: 16170348 [TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies. Panwalkar A; Verstovsek S; Giles F Cancer; 2004 Apr; 100(8):1578-89. PubMed ID: 15073843 [TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Lin YG; Kunnumakkara AB; Nair A; Merritt WM; Han LY; Armaiz-Pena GN; Kamat AA; Spannuth WA; Gershenson DM; Lutgendorf SK; Aggarwal BB; Sood AK Clin Cancer Res; 2007 Jun; 13(11):3423-30. PubMed ID: 17545551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]